Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
85.00
Ask:
90.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

mpro5 healthcare update

5 Jul 2018 08:38

RNS Number : 7090T
Crimson Tide PLC
05 July 2018
 

Crimson Tide plc ("Crimson Tide" or the "Company")

Continued investment in mpro5 for healthcare sees GCloud accreditation contract awards.

 

Crimson Tide is pleased to announce it has continued to add subscribers in the healthcare sector from its investments in R&D and marketing. Critical to our growth in the UK healthcare sector and specifically the public bodies responsible for delivery, it is also with great pleasure that the Company announces that mpro5 has been accepted to GCloud 10, the government marketplace for applications.

A global healthcare organisation has completed a second successful pilot of mpro5 for the identification and reporting of falsified and fraudulent medication. These pilots have been carried out in emerging nations where the effectiveness of contraceptives and anti-malarial medicines are critical to the economic and social development of the country as a whole. mpro5 has positively detected multiple instances of falsified medicine in the pilot areas. The Company is hopeful that further collaboration could lead to full rollouts in the pilot countries and other uses of mpro5 are under discussion.

Crimson Tide is in the process of adding a new biometric time and attendance module to mpro5 for a NHS trust in the North West of England, leveraging scanning capabilities to guarantee correct identification of individuals arriving on site.

The Company has also won a contract to aid AVM Services, which operates within Cambridge University Hospitals NHS Foundation Trust, with decontamination activities which are conducted in accordance with standardised UK regulatory procedures. mpro5 allows the scheduling of regular tasks in respect of porous loads and instruments including sterilizers, disinfectors and endoscopes. The commissioning of decontamination equipment is achieved through an mpro5 workflow that automatically awards the relevant compliance or commissioning document based on a complex scoring method.

A variety of our existing facilities management clients have continued the rollout of 49 point NHS cleaning compliance checks adding an increasing number of healthcare facilities to the locations where mpro5 is in daily use.

Crimson Tide's Executive Chairman, Barrie Whipp commented. "It is pleasing to hear of the NHS commitment to mobile applications for patients. mpro5 is a tactical solution to healthcare scenarios for not only patients, but clinicians and organisations that participate in the healthcare supply chain. We are now GCloud approved allowing us to push on with our investments and bring real change to processes in the state and private sector, locally and internationally"

‐ ends ‐

 For further information:

Crimson Tide plc Barrie Whipp / Luke Jeffrey / Steve Goodwin 01892 542 444

Arden Partners plc (Nomad/Broker) Steve Douglas / Dan Gee-Summons 020 7614 5900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAXXSEDKPEEF
Date   Source Headline
5th Jun 202612:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSYear End Trading Update
24th Apr 20267:00 amRNSAIM Director Disclosure Update
2nd Apr 20267:00 amRNS-RNew Contract Wins
9th Mar 202610:00 amRNSConcert Party Update
26th Feb 20267:00 amRNSNon-Executive Director Appointments
18th Feb 20267:00 amRNS-RRenewal of Contract
23rd Jan 20267:00 amRNSChange of Non-Executive Director
29th Dec 20259:21 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSCustomer Contracts Update
4th Dec 20255:43 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
19th Nov 20257:00 amRNSInterim Results
10th Nov 20253:14 pmRNSContract Renewal with Major Global Retailer
3rd Nov 20254:20 pmRNSHolding(s) in Company
31st Oct 20252:46 pmRNSResult of AGM
31st Oct 20259:28 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSAGM Statement
27th Oct 20254:45 pmRNSHolding(s) in Company
27th Oct 20254:43 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSAudited Full Year Results
29th Sep 20257:00 amRNSUpdate on Audited Results
22nd Jul 20257:00 amRNSAppointment of Chief Executive Officer
14th Jul 20252:40 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSContract Renewal with Major UK Wholesaler
4th Jul 20257:00 amRNSAppointment of Finance Director
12th Jun 202510:46 amRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Chair, Nominated Adviser and Broker
30th May 20257:00 amRNSSecond Interim Results
29th May 20257:00 amRNSContract Renewal with Major British Supermarket
6th May 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:58 pmRNSBoard Appointment
26th Mar 202511:00 amRNSBoard Changes
20th Mar 20252:29 pmRNSBoard Change
20th Mar 202512:36 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:25 amRNSForm 8.5 (EPT/RI)
19th Mar 202511:50 amRNSResults of Court Meeting and General Meeting
18th Mar 20259:35 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20253:06 pmGNWForm 8.3 - Crimson Tide Plc
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI)
14th Mar 20253:05 pmGNWForm 8.3 - Crimson Tide Plc
14th Mar 202511:58 amRNSForm 8.5 (EPT/RI)
12th Mar 202512:05 pmRNSForm 8.5 (EPT/RI)
12th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 202510:32 amRNSForm 8.5 (EPT/RI)
11th Mar 20257:00 amRNSOffer Update
10th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc
7th Mar 202510:20 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.